Journal of Immunology Research
Volume 2017 (2017), Article ID 6073961, 1 page
https://doi.org/10.1155/2017/6073961

Corrigendum

Corrigendum to “The Controversial C5a Receptor C5aR2: Its Role in Health and Disease”

Ting Zhang, Malgorzata A. Garstka, and Ke Li

Core Research Laboratory, The Second Affiliated Hospital, Xi’an Jiaotong University, Xi’an, Shaanxi, China

Correspondence should be addressed to Ke Li; ke.li@mail.xjtu.edu.cn

Received 10 September 2017; Accepted 16 October 2017; Published 1 November 2017

Copyright © 2017 Ting Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “The Controversial C5a Receptor C5aR2: Its Role in Health and Disease” [1], there was an error in Table 4, where Jun/fos-A8△71–73 should be corrected to A8△71–73. The corrected table is as follows:

Table 4: C5aR2 agonists and antagonists.

Ligand
Specificity
Function
Refs

Jun/fos-A8
A8△71–73
C5 mutant peptides
Human and murine C5aR1 and C5aR2
Antagonists—block binding of C5a and C5a
des Arg to C5aRs
[51]

P32, P59—C terminal peptides of C5a
hC5aR2
Agonists—strongly stimulate the association of hC5aR2 with β-arrestin 2
[21, 127]

LukS-PV—protein from S. aureus
Human and rabbit C5aR1
Human, macaque, and rabbit C5aR2
Antagonist of C5a-induced activation of neutrophils
[48, 128]

HIgCB—protein complex from S. aureus
Human, macaque, rabbit, and cow C5aRs
Antagonist of C5a-induced activation of neutrophils
[128, 129]

References

T. Zhang, M. A. Garstka, and K. Li, “The controversial C5a receptor C5aR2: its role in health and disease,” Journal of Immunology Research, vol. 2017, Article ID 8193932, 16 pages, 2017.